Variability of Adjustments to Indices in Determining Patient Risk in Biochemical Screening

It has long been appreciated that the measurement of biochemical parameters for prenatal screening for neural tube defects, and later aneuploidy, is not as simple as measuring hemoglobin or hematocrit